Form 4: Core Labs Officer Teo Sow Hang Reports Share Transactions

Core Laboratories Inc. CAO & Treasurer Teo Sow Hang reported the acquisition of 864 common shares from restricted stock vesting and the disposition of 340 shares for tax withholding.

Summary

• Teo Sow Hang, CAO & Treasurer of Core Laboratories Inc., reported transactions on December 1, 2025.
• Acquired 864 shares of common stock at a price of $0, resulting from the vesting of restricted shares.
• Disposed of 340 shares of common stock at $15.39 per share, likely to cover tax obligations related to the vesting.
• Following these transactions, direct beneficial ownership of common stock is 8,765.334 shares.
• The reporting person also holds 6,690 unvested restricted shares, which vest annually over six years.

Sentiment

Score: 7

Explanation: The filing reflects a routine executive compensation event (restricted stock vesting and tax-related sale). It's generally positive as it shows continued alignment of management with shareholder interests through equity ownership, despite a minor disposition for tax purposes.

Positives

• Vesting of restricted shares indicates continued employment and long-term incentive alignment between the officer and the company.
• The acquisition of 864 common shares at $0 increases the officer's direct ownership in the company, demonstrating commitment.

Negatives

• Disposition of 340 shares, even for tax purposes, results in a reduction of the officer's direct shareholding.

Future Outlook

The filing indicates that the reporting person holds 6,690 unvested restricted shares, which are scheduled to vest annually over six years, contingent on continuous service. This suggests a long-term incentive structure for the officer.

Industry Context

This Form 4 filing reflects routine insider transactions related to executive compensation, specifically the vesting of restricted stock and subsequent tax-related share dispositions. Such transactions are common across industries as part of executive incentive plans and do not typically indicate a shift in broader industry trends for the oilfield services sector where Core Laboratories operates.

Comparison to Industry Standards

• The vesting of restricted shares and subsequent sale for tax purposes is a standard practice in executive compensation across publicly traded companies.
• The specific number of shares and vesting schedule are consistent with typical long-term incentive plans designed to align management interests with shareholder value over several years.
• No specific comparable companies or projects are mentioned in this filing to provide a direct comparison of results.

Stakeholder Impact

• Shareholders: The officer's increased direct ownership (net of tax sales) aligns management interests with shareholder value. The disposition for tax purposes is a minor, routine event.
• Employees: The vesting schedule reinforces the importance of continuous service for executive compensation.

Next Steps

• Future annual vesting events for the remaining 6,690 restricted shares, contingent on continuous service.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to executive compensation (restricted stock vesting and tax-related sales). It does not provide new fundamental information about the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. The transactions are expected and reflect standard compensation practices, thus maintaining a 'hold' stance is appropriate based solely on this filing.

Keywords

Core Laboratories Inc., CLB, Form 4, Insider Trading, Restricted Stock, Stock Vesting, Officer Transactions, Teo Sow Hang, Common Stock